Biosort is an Oslo-based aquaculture technology company focused on improving salmon farming through automated, data-driven tools. Its flagship platform, iFarm, identifies and tracks individual salmon inside sea pens, enabling farmers to monitor health and growth in real time. Building on this capability, the firm has engineered a complementary lice-control system that targets and removes sea lice at an early stage, aiming to curb infestations before they require large-scale wellboat treatments. Management claims the approach will enhance fish welfare, lower mortality, and reduce operational costs tied to lice mitigation. The newly raised capital will fund the final development steps and initial commercial roll-out of the lice-removal technology, which will be tightly integrated with iFarm. While no revenue or deployment figures were disclosed, the company positions this round as the bridge from R&D to commercial sales, indicating an imminent shift toward scaled market adoption.

Total raised

$11M

Funding rounds

1

Latest round

Equity

Latest activity

Mar 2026